| Long-term results after microsurgery for Cushing disease: experience with 426 primary operations over 35 years BM Hofmann, M Hlavac, R Martinez, M Buchfelder, OA Müller, ... Journal of neurosurgery 108 (1), 9-18, 2008 | 217 | 2008 |
| Tumor detection with 5-aminolevulinic acid fluorescence and Gd-DTPA–enhanced intraoperative MRI at the border of contrast-enhancing lesions: a prospective study based on … J Coburger, J Engelke, A Scheuerle, DR Thal, M Hlavac, CR Wirtz, ... Neurosurgical focus 36 (2), E3, 2014 | 150 | 2014 |
| Surgical treatment of recurrent Cushing's disease BM Hofmann, M Hlavac, J Kreutzer, G Grabenbauer, R Fahlbusch Neurosurgery 58 (6), 1108-1118, 2006 | 74 | 2006 |
| Immune phenotypes predict survival in patients with glioblastoma multiforme H Mostafa, A Pala, J Högel, M Hlavac, E Dietrich, MA Westhoff, ... Journal of hematology & oncology 9, 1-14, 2016 | 73 | 2016 |
| Determining the utility of intraoperative magnetic resonance imaging for transsphenoidal surgery: a retrospective study J Coburger, R König, K Seitz, U Bäzner, CR Wirtz, M Hlavac Journal of neurosurgery 120 (2), 346-356, 2014 | 64 | 2014 |
| Linear array ultrasound in low-grade glioma surgery: histology-based assessment of accuracy in comparison to conventional intraoperative ultrasound and intraoperative MRI J Coburger, A Scheuerle, DR Thal, J Engelke, M Hlavac, CR Wirtz, ... Acta neurochirurgica 157, 195-206, 2015 | 60 | 2015 |
| Olanzapine inhibits proliferation, migration and anchorage-independent growth in human glioblastoma cell lines and enhances temozolomide’s antiproliferative effect G Karpel-Massler, RE Kast, MA Westhoff, A Dwucet, N Welscher, ... Journal of neuro-oncology 122, 21-33, 2015 | 53 | 2015 |
| Navigated high frequency ultrasound: description of technique and clinical comparison with conventional intracranial ultrasound J Coburger, RW König, A Scheuerle, J Engelke, M Hlavac, DR Thal, ... World neurosurgery 82 (3-4), 366-375, 2014 | 53 | 2014 |
| Augmented reality–assisted ventriculostomy M Schneider, C Kunz, A Pal’a, CR Wirtz, F Mathis-Ullrich, M Hlaváč Neurosurgical focus 50 (1), E16, 2021 | 45 | 2021 |
| Dual metabolic reprogramming by ONC201/TIC10 and 2-Deoxyglucose induces energy depletion and synergistic anti-cancer activity in glioblastoma M Pruss, A Dwucet, M Tanriover, M Hlavac, RE Kast, KM Debatin, ... British journal of cancer 122 (8), 1146-1157, 2020 | 40 | 2020 |
| Infrared marker tracking with the HoloLens for neurosurgical interventions C Kunz, P Maurer, F Kees, P Henrich, C Marzi, M Hlaváč, M Schneider, ... Current Directions in Biomedical Engineering 6 (1), 20200027, 2020 | 36 | 2020 |
| The value of intraoperative magnetic resonance imaging in endoscopic and microsurgical transsphenoidal pituitary adenoma resection A Pal'a, A Knoll, C Brand, G Etzrodt-Walter, J Coburger, CR Wirtz, ... World neurosurgery 102, 144-150, 2017 | 36 | 2017 |
| Bcl‐2/Bcl‐xL inhibition predominantly synergistically enhances the anti‐neoplastic activity of a low‐dose CUSP9 repurposed drug regime against glioblastoma ME Halatsch, RE Kast, A Dwucet, M Hlavac, T Heiland, MA Westhoff, ... British Journal of Pharmacology 176 (18), 3681-3694, 2019 | 28 | 2019 |
| The value of intraoperative and early postoperative magnetic resonance imaging in low-grade glioma surgery: a retrospective study A Pala, C Brand, T Kapapa, M Hlavac, R König, B Schmitz, CR Wirtz, ... World Neurosurgery 93, 191-197, 2016 | 26 | 2016 |
| Intraoperative MRI in transsphenoidal resection of invasive pituitary macroadenomas M Hlaváč, A Knoll, G Etzrodt-Walter, F Sommer, M Scheithauer, ... Neurosurgical Review 42, 737-743, 2019 | 21 | 2019 |
| Ten years’ experience with intraoperative MRI-assisted transsphenoidal pituitary surgery M Hlaváč, A Knoll, B Mayer, M Braun, G Karpel-Massler, G Etzrodt-Walter, ... Neurosurgical focus 48 (6), E14, 2020 | 17 | 2020 |
| Combined inhibition of RAC1 and Bcl-2/Bcl-xL synergistically induces glioblastoma cell death through down-regulation of the Usp9X/Mcl-1 axis M Hlavac, A Dwucet, RE Kast, J Engelke, MA Westhoff, MD Siegelin, ... Cellular Oncology 42, 287-301, 2019 | 15 | 2019 |
| Lows and highs: 15 years of development in intraoperative magnetic resonance imaging T Schmidt, R König, M Hlavac, G Antoniadis, CR Wirtz Intraoperative imaging, 17-20, 2011 | 15 | 2011 |
| Intraoperative Magnetresonanztomographie M Hlavac, R König, M Halatsch, CR Wirtz Der Unfallchirurg 115 (2), 121-124, 2012 | 14* | 2012 |
| Is MGMT promoter methylation to be considered in the decision making for recurrent surgery in glioblastoma patients? A Pala, AL Schmitz, A Knoll, M Schneider, M Hlavac, R König, CR Wirtz, ... Clinical Neurology and Neurosurgery 167, 6-10, 2018 | 13 | 2018 |
